相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Revisiting protein aggregation as pathogenic in sporadic Parkinson and Alzheimer diseases
Alberto J. Espay et al.
NEUROLOGY (2019)
Bidirectional modulation of Alzheimer phenotype by alpha-synuclein in mice and primary neurons
Shahzad S. Khan et al.
ACTA NEUROPATHOLOGICA (2018)
Cerebrospinal fluid α-synuclein contributes to the differential diagnosis of Alzheimer's disease
Min Shi et al.
ALZHEIMERS & DEMENTIA (2018)
NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
Clifford R. Jack et al.
ALZHEIMERS & DEMENTIA (2018)
Molecular biomarkers of Alzheimer's disease: progress and prospects
Tammaryn Lashley et al.
DISEASE MODELS & MECHANISMS (2018)
Crucial role of protein oligomerization in the pathogenesis of Alzheimer's and Parkinson's diseases
Minee L. Choi et al.
FEBS JOURNAL (2018)
A Longitudinal Study of Total and Phosphorylated alpha-Synuclein with Other Biomarkers in Cerebrospinal Fluid of Alzheimer's Disease and Mild Cognitive Impairment
Hua Wang et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
The Amyloid-beta Oligomer Hypothesis: Beginning of the Third Decade
Erika N. Cline et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Multiple system atrophy and apolipoprotein E
Kotaro Ogaki et al.
MOVEMENT DISORDERS (2018)
Distinct alpha-Synuclein strains and implications for heterogeneity among alpha-Synucleinopathies
Chao Peng et al.
NEUROBIOLOGY OF DISEASE (2018)
C-terminal calcium binding of alpha-synuclein modulates synaptic vesicle interaction
Janin Lautenschlager et al.
NATURE COMMUNICATIONS (2018)
Improving the identification of dementia with Lewy bodies in the context of an Alzheimer's-type dementia
Alan J. Thomas et al.
ALZHEIMERS RESEARCH & THERAPY (2018)
Cerebrospinal fluid in the differential diagnosis of Alzheimer's disease: clinical utility of an extended panel of biomarkers in a specialist cognitive clinic
Ross W. Paterson et al.
ALZHEIMERS RESEARCH & THERAPY (2018)
Cryo-EM structure of alpha-synuclein fibrils
Ricardo Guerrero-Ferreira et al.
ELIFE (2018)
Import and Export of Misfoldeda alpha-Synuclein
Lilia Rodriguez et al.
FRONTIERS IN NEUROSCIENCE (2018)
Altered CSF Orexin and α-Synuclein Levels in Dementia Patients
Malin Wennström et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Lipid-dependent deposition of alpha-synuclein and Tau on neuronal Secretogranin II-positive vesicular membranes with age
Oeystein R. Brekk et al.
SCIENTIFIC REPORTS (2018)
Rationally Designed Variants of alpha-Synuclein Illuminate Its in vivo Structural Properties in Health and Disease
Ulf Dettmer
FRONTIERS IN NEUROSCIENCE (2018)
Association of cerebrospinal fluid α-synuclein with total and phospho-tau181 protein concentrations and brain amyloid load in cognitively normal subjective memory complainers stratified by Alzheimer's disease biomarkers
Andrea Vergallo et al.
ALZHEIMERS & DEMENTIA (2018)
The relevance of cerebrospinal fluid -synuclein levels to sporadic and familial Alzheimer's disease
Daniel Twohig et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2018)
Human Astrocytes Transfer Aggregated Alpha-Synuclein via Tunneling Nanotubes
Jinar Rostami et al.
JOURNAL OF NEUROSCIENCE (2017)
Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers
Giovanni B. Frisoni et al.
LANCET NEUROLOGY (2017)
Tau PET imaging: present and future directions
Laure Saint-Aubert et al.
MOLECULAR NEURODEGENERATION (2017)
α-Synuclein promotes dilation of the exocytotic fusion pore
Todd Logan et al.
NATURE NEUROSCIENCE (2017)
Selective lowering of synapsins induced by oligomeric α-synuclein exacerbates memory deficits
Megan E. Larson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Increased levels of CSF total but not oligomeric or phosphorylated forms of alpha-synuclein in patients diagnosed with probable Alzheimer's disease
Nour K. Majbour et al.
SCIENTIFIC REPORTS (2017)
Early- versus late-onset Alzheimer's disease in clinical practice: cognitive and global outcomes over 3 years
Carina Wattmo et al.
ALZHEIMERS RESEARCH & THERAPY (2017)
Brain-derived exosomes from dementia with Lewy bodies propagate α-synuclein pathology
Jennifer Ngolab et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2017)
α-synuclein transfer through tunneling nanotubes occurs in SH-SY5Y cells and primary brain pericytes from Parkinson's disease patients
Birger Victor Dieriks et al.
SCIENTIFIC REPORTS (2017)
Tau pathology and neurodegeneration contribute to cognitive impairment in Alzheimer's disease
Alexandre Bejanin et al.
BRAIN (2017)
A Review of Fluid Biomarkers for Alzheimer's Disease: Moving from CSF to Blood
Kaj Blennow
NEUROLOGY AND THERAPY (2017)
Steady-State Kinetics of a-Synuclein Ferrireductase Activity Identifies the Catalytically Competent Species
Jennifer S. McDowall et al.
BIOCHEMISTRY (2017)
Recommendations for CSF AD biomarkers in the diagnostic evaluation of dementia
Anja Hviid Simonsen et al.
ALZHEIMERS & DEMENTIA (2017)
Recommendations for cerebrospinal fluid Alzheimer's disease biomarkers in the diagnostic evaluation of mild cognitive impairment
Sanna-Kaisa Herukka et al.
ALZHEIMERS & DEMENTIA (2017)
Pathological α-synuclein distribution in subjects with coincident Alzheimer's and Lewy body pathology
Jon B. Toledo et al.
ACTA NEUROPATHOLOGICA (2016)
Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria
Bruno Dubois et al.
ALZHEIMERS & DEMENTIA (2016)
Knockdown of α-synuclein in cerebral cortex improves neural behavior associated with apoptotic inhibition and neurotrophin expression in spinal cord transected rats
You-Cui Wang et al.
APOPTOSIS (2016)
Alpha-synuclein measured in cerebrospinal fluid from patients with Alzheimer's disease, mild cognitive impairment, or healthy controls: a two year follow-up study
Guro Berge et al.
BMC NEUROLOGY (2016)
Non-Demented Individuals with Alzheimer's Disease Neuropathology: Resistance to Cognitive Decline May Reveal New Treatment Strategies
Olga Zolochevska et al.
CURRENT PHARMACEUTICAL DESIGN (2016)
Tunneling nanotubes spread fibrillar α-synuclein by intercellular trafficking of lysosomes
Saida Abounit et al.
EMBO JOURNAL (2016)
The amyloid hypothesis of Alzheimer's disease at 25years
Dennis J. Selkoe et al.
EMBO MOLECULAR MEDICINE (2016)
α-Synuclein Fibrils Exhibit Gain of Toxic Function, Promoting Tau Aggregation and Inhibiting Microtubule Assembly
Takayuki Oikawa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Reducing Endogenous α-Synuclein Mitigates the Degeneration of Selective Neuronal Populations in an Alzheimer's Disease Transgenic Mouse Model
Brian Spencer et al.
JOURNAL OF NEUROSCIENCE (2016)
Apolipoprotein E lipoprotein particles inhibit amyloid-β uptake through cell surface heparan sulphate proteoglycan
Yuan Fu et al.
MOLECULAR NEURODEGENERATION (2016)
Extensive graft-derived dopaminergic innervation is maintained 24 years after transplantation in the degenerating parkinsonian brain
Wen Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
The Parkinson Disease gene SNCA: Evolutionary and structural insights with pathological implication
Irum Javaid Siddiqui et al.
SCIENTIFIC REPORTS (2016)
Summary of the evidence on modifiable risk factors for cognitive decline and dementia: A population-based perspective
Matthew Baumgart et al.
ALZHEIMERS & DEMENTIA (2015)
Use of CSF α-synuclein in the differential diagnosis between Alzheimer's disease and other neurodegenerative disorders
Zheng-Yu Wang et al.
INTERNATIONAL PSYCHOGERIATRICS (2015)
The case for rejecting the amyloid cascade hypothesis
Karl Herrup
NATURE NEUROSCIENCE (2015)
Validation of a quantitative cerebrospinal fluid alpha-synuclein assay in a European-wide interlaboratory study
Niels Kruse et al.
NEUROBIOLOGY OF AGING (2015)
KTKEGV repeat motifs are key mediators of normal α-synuclein tetramerization: Their mutation causes excess monomers and neurotoxicity
Ulf Dettmer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Alzheimer's and Parkinson's diseases: The prion concept in relation to assembled Aβ, tau, and α-synuclein
Michel Goedert
SCIENCE (2015)
Parkinson-causing α-synuclein missense mutations shift native tetramers to monomers as a mechanism for disease initiation
Ulf Dettmer et al.
NATURE COMMUNICATIONS (2015)
Amyloidogenic α-synuclein seeds do not invariably induce rapid, widespread pathology in mice
Amanda N. Sacino et al.
ACTA NEUROPATHOLOGICA (2014)
Increased CSF α-synuclein levels in Alzheimer's disease: Correlation with tau levels
Sylvie Slaets et al.
ALZHEIMERS & DEMENTIA (2014)
Convergence of pathology in dementia with Lewy bodies and Alzheimer's disease: a role for the novel interaction of alpha-synuclein and presenilin 1 in disease
Ashley R. Winslow et al.
BRAIN (2014)
α-Synuclein Multimers Cluster Synaptic Vesicles and Attenuate Recycling
Lina Wang et al.
CURRENT BIOLOGY (2014)
Reduced α-synuclein levels in cerebrospinal fluid in Parkinson's disease are unrelated to clinical and imaging measures of disease severity
K. D. van Dijk et al.
EUROPEAN JOURNAL OF NEUROLOGY (2014)
Low Levels of Soluble NG2 in Cerebrospinal Fluid from Patients with Dementia with Lewy Bodies
Henrietta M. Nielsen et al.
JOURNAL OF ALZHEIMERS DISEASE (2014)
Spreading of Amyloid, Tau, and Microvascular Pathology in Alzheimer's Disease: Findings from Neuropathological and Neuroimaging Studies
Dietmar Rudolf Thal et al.
JOURNAL OF ALZHEIMERS DISEASE (2014)
Apolipoprotein E ε2 genotype delays onset of dementia with Lewy bodies in a Norwegian cohort
Guro Berge et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2014)
Alpha-synuclein and tau: teammates in neurodegeneration?
Simon Moussaud et al.
MOLECULAR NEURODEGENERATION (2014)
Defining the Native State of α-Synuclein
Dennis Selkoe et al.
NEURODEGENERATIVE DISEASES (2014)
Extracellular α-Synuclein Leads to Microtubule Destabilization via GSK-3β-Dependent Tau Phosphorylation in PC12 Cells
Magdalena Gassowska et al.
PLOS ONE (2014)
α-Synuclein assembles into higher-order multimers upon membrane binding to promote SNARE complex formation
Jacqueline Burre et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Levels of cerebrospinal fluid α-synuclein oligomers are increased in Parkinson's disease with dementia and dementia with Lewy bodies compared to Alzheimer's disease
Oskar Hansson et al.
ALZHEIMERS RESEARCH & THERAPY (2014)
The clinical characteristics of dementia with Lewy bodies and a consideration of prodromal diagnosis
Paul C. Donaghy et al.
ALZHEIMERS RESEARCH & THERAPY (2014)
CSF α-synuclein improves diagnostic and prognostic performance of CSF tau and Aβ in Alzheimer's disease
Jon B. Toledo et al.
ACTA NEUROPATHOLOGICA (2013)
Tau protein kinases: Involvement in Alzheimer's disease
Ludovic Martin et al.
AGEING RESEARCH REVIEWS (2013)
The Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception
Michael W. Weiner et al.
Alzheimers & Dementia (2013)
G51D α-Synuclein mutation causes a novel Parkinsonian-pyramidal syndrome
Suzanne Lesage et al.
ANNALS OF NEUROLOGY (2013)
alpha-Synuclein in Cerebrospinal Fluid of Alzheimer's Disease and Mild Cognitive Impairment
Ane Korff et al.
JOURNAL OF ALZHEIMERS DISEASE (2013)
In Vivo Cross-linking Reveals Principally Oligomeric Forms of α-Synuclein and β-Synuclein in Neurons and Non-neural Cells
Ulf Dettmer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
The Mysterious C-Terminal Tail of Alpha-Synuclein: Nanobody's Guess
David Eliezer
JOURNAL OF MOLECULAR BIOLOGY (2013)
Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers
Clifford R. Jack et al.
LANCET NEUROLOGY (2013)
Function and Dysfunction of α-Synuclein: Probing Conformational Changes and Aggregation by Single Molecule Fluorescence
Adam J. Trexler et al.
MOLECULAR NEUROBIOLOGY (2013)
Lentivirus Mediated Delivery of Neurosin Promotes Clearance of Wild-type α-Synuclein and Reduces the Pathology in an α-Synuclein Model of LBD
Brian Spencer et al.
MOLECULAR THERAPY (2013)
Alpha-synuclein p.H50Q, a novel pathogenic mutation for Parkinson's disease
Silke Appel-Cresswell et al.
MOVEMENT DISORDERS (2013)
Self-propagation of pathogenic protein aggregates in neurodegenerative diseases
Mathias Jucker et al.
NATURE (2013)
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease
Jean-Charles Lambert et al.
NATURE GENETICS (2013)
Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy
Chia-Chan Liu et al.
NATURE REVIEWS NEUROLOGY (2013)
Alzheimer disease in the United States (2010-2050) estimated using the 2010 census
Liesi E. Hebert et al.
NEUROLOGY (2013)
Low CSF Levels of Both α-Synuclein and the α-Synuclein Cleaving Enzyme Neurosin in Patients with Synucleinopathy
Malin Wennstrom et al.
PLOS ONE (2013)
The Diagnostic Value of CSF α-Synuclein in the Differential Diagnosis of Dementia with Lewy Bodies vs. Normal Subjects and Patients with Alzheimer's Disease
Elisabeth Kapaki et al.
PLOS ONE (2013)
Heparan sulfate proteoglycans mediate internalization and propagation of specific proteopathic seeds
Brandon B. Holmes et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Biomarkers for Alzheimer's disease in plasma, serum and blood - conceptual and practical problems
Douglas Galasko et al.
ALZHEIMERS RESEARCH & THERAPY (2013)
Clinical, imaging, and pathological heterogeneity of the Alzheimer's disease syndrome
Benjamin Lam et al.
ALZHEIMERS RESEARCH & THERAPY (2013)
Incidence of Dementia With Lewy Bodies and Parkinson Disease Dementia
Rodolfo Savica et al.
JAMA NEUROLOGY (2013)
Alpha-synuclein in the Cerebrospinal Fluid Differentiates Synucleinopathies (Parkinson Disease, Dementia With Lewy Bodies, Multiple System Atrophy) From Alzheimer Disease
Fuyuki Tateno et al.
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2012)
Exosome-associated Tau Is Secreted in Tauopathy Models and Is Selectively Phosphorylated in Cerebrospinal Fluid in Early Alzheimer Disease
Sudad Saman et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Soluble α-Synuclein Is a Novel Modulator of Alzheimer's Disease Pathophysiology
Megan E. Larson et al.
JOURNAL OF NEUROSCIENCE (2012)
α-Synuclein Inhibits Intersynaptic Vesicle Mobility and Maintains Recycling-Pool Homeostasis
David Scott et al.
JOURNAL OF NEUROSCIENCE (2012)
Impaired neurotransmission caused by overexpression of α-synuclein in nigral dopamine neurons
Martin Lundblad et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Epidemiology of Alzheimer Disease
Richard Mayeux et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
Trafficking and Proteolytic Processing of APP
Christian Haass et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Reisa A. Sperling et al.
ALZHEIMERS & DEMENTIA (2011)
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Guy M. McKhann et al.
ALZHEIMERS & DEMENTIA (2011)
The amyloid cascade hypothesis has misled the pharmaceutical industry
[Anonymous]
BIOCHEMICAL SOCIETY TRANSACTIONS (2011)
Stimulatory effect of α-synuclein on the tau-phosphorylation by GSK-3ß
Fumitaka Kawakami et al.
FEBS JOURNAL (2011)
The role of the C-terminus of human α-synuclein: Intra-disulfide bonds between the C-terminus and other regions stabilize non-fibrillar monomeric isomers
Dong-Pyo Hong et al.
FEBS LETTERS (2011)
Induction of Intracellular Tau Aggregation Is Promoted by α-Synuclein Seeds and Provides Novel Insights into the Hyperphosphorylation of Tau
Elisa A. Waxman et al.
JOURNAL OF NEUROSCIENCE (2011)
The projected effect of risk factor reduction on Alzheimer's disease prevalence
Deborah E. Barnes et al.
LANCET NEUROLOGY (2011)
α-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation
Tim Bartels et al.
NATURE (2011)
Role of Rab GTPases in Membrane Traffic and Cell Physiology
Alex H. Hutagalung et al.
PHYSIOLOGICAL REVIEWS (2011)
A soluble α-synuclein construct forms a dynamic tetramer
Wei Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
DJ-1 and α-synuclein in human cerebrospinal fluid as biomarkers of Parkinson's disease
Zhen Hong et al.
BRAIN (2010)
CSF alpha-Synuclein Does Not Discriminate Dementia with Lewy Bodies from Alzheimer's Disease
Fransje E. Reesink et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
Lysosomal Degradation of α-Synuclein in Vivo
Sally K. Mak et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
The Lipid-binding Domain of Wild Type and Mutant α-Synuclein COMPACTNESS AND INTERCONVERSION BETWEEN THE BROKEN AND EXTENDED HELIX FORMS
Elka R. Georgieva et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Differential levels of α-synuclein, β-amyloid42 and tau in CSF between patients with dementia with Lewy bodies and Alzheimer's disease
Kensaku Kasuga et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2010)
A Pathologic Cascade Leading to Synaptic Dysfunction in α-Synuclein-Induced Neurodegeneration
David A. Scott et al.
JOURNAL OF NEUROSCIENCE (2010)
Synergistic Interactions between Aβ, Tau, and α-Synuclein: Acceleration of Neuropathology and Cognitive Decline
Lani K. Clinton et al.
JOURNAL OF NEUROSCIENCE (2010)
Cell-Produced α-Synuclein Is Secreted in a Calcium-Dependent Manner by Exosomes and Impacts Neuronal Survival
Evangelia Emmanouilidou et al.
JOURNAL OF NEUROSCIENCE (2010)
Revising the definition of Alzheimer's disease: a new lexicon
Bruno Dubois et al.
LANCET NEUROLOGY (2010)
Increased Expression of α-Synuclein Reduces Neurotransmitter Release by Inhibiting Synaptic Vesicle Reclustering after Endocytosis
Venu M. Nemani et al.
NEURON (2010)
Extracellular neurosin degrades α-synuclein in cultured cells
Harutsugu Tatebe et al.
NEUROSCIENCE RESEARCH (2010)
αβγ-Synuclein triple knockout mice reveal age-dependent neuronal dysfunction
Becket Greten-Harrison et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Classification and basic pathology of Alzheimer disease
Charles Duyckaerts et al.
ACTA NEUROPATHOLOGICA (2009)
Extrapyramidal Signs Before and After Diagnosis of Incident Alzheimer Disease in a Prospective Population Study
Florence Portet et al.
ARCHIVES OF NEUROLOGY (2009)
α-Synuclein Binds Large Unilamellar Vesicles as an Extended Helix
Adam J. Trexler et al.
BIOCHEMISTRY (2009)
α-Synuclein contributes to GSK-3β-catalyzed Tau phosphorylation in Parkinson's disease models
Tetyana Duka et al.
FASEB JOURNAL (2009)
Cerebrospinal Fluid alpha-Synuclein Does Not Discriminate Between Dementia Disorders
Petra E. Spies et al.
JOURNAL OF ALZHEIMERS DISEASE (2009)
Functional dissection of the α-synuclein promoter: transcriptional regulation by ZSCAN21 and ZNF219
Richard Lee Clough et al.
JOURNAL OF NEUROCHEMISTRY (2009)
Lewy Body Pathology in Normal Elderly Subjects
William R. Markesbery et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2009)
Cerebrospinal fluid α-synuclein in neurodegenerative disorders-A marker of synapse loss?
Annika Ohrfelt et al.
NEUROSCIENCE LETTERS (2009)
Interplay of α-synuclein binding and conformational switching probed by single-molecule fluorescence
Allan Chris M. Ferreon et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Exogenous α-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells
Kelvin C. Luk et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Direct quantification of CSF α-synuclein by ELISA and first cross-sectional study in patients with neurodegeneration
Brit Mollenhauer et al.
EXPERIMENTAL NEUROLOGY (2008)
Controlling the mass action of alpha-synuclein in Parkinson's disease
Changyoun Kim et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation
Jia-Yi Li et al.
NATURE MEDICINE (2008)
Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease
Jeffrey H. Kordower et al.
NATURE MEDICINE (2008)
A molecular pathway of neurodegeneration linking α-synuclein to ApoE and Aβ peptides
Gilbert Gallardo et al.
NATURE NEUROSCIENCE (2008)
Cleavage of normal and pathological forms of α-synuclein by neurosin in vitro
Takashi Kasai et al.
NEUROSCIENCE LETTERS (2008)
Mechanisms of Hybrid Oligomer Formation in the Pathogenesis of Combined Alzheimer's and Parkinson's Diseases
Igor F. Tsigelny et al.
PLOS ONE (2008)
GATA transcription factors directly regulate the Parkinson's disease-linked gene α-synuclein
Clemens R. Scherzer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Enhanced accumulation of phosphorylated α-synuclein and elevated β-amyloid 42/40 ratio caused by expression of the presenilin-1 ΔT440 mutant associated with familial Lewy body disease and variant Alzheimer's disease
Hiroyuki Kaneko et al.
JOURNAL OF NEUROSCIENCE (2007)
Paramagnetism-based NMR restraints provide maximum allowed probabilities for the different conformations of partially independent protein domains
Ivano Bertini et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2007)
Decreased α-synuclein in cerebrospinal fluid of aged individuals and subjects with Parkinson's disease
Takahiko Tokuda et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Interaction between Aβ peptide and α synuclein:: Molecular mechanisms in overlapping pathology of Alzheimer's and Parkinson's in dementia with Lewy body disease
Pravat K. Mandal et al.
NEUROCHEMICAL RESEARCH (2006)
Alzheimer disease with amygdala Lewy bodies:: A distinct form of α-synucleinopathy
Hirotake Uchikado et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2006)
Lewy body pathology in familial Alzheimer disease - Evidence for disease- and mutation-specific pathologic phenotype
JB Leverenz et al.
ARCHIVES OF NEUROLOGY (2006)
Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Aβ42 in humans
AM Fagan et al.
ANNALS OF NEUROLOGY (2006)
Highly potent and specific GSK-3β inhibitors that block Tau phosphorylation and decrease α-synuclein protein expression in a cellular model of Parkinson's disease
Alan P. Kozikowski et al.
CHEMMEDCHEM (2006)
Novel presenilin 1 mutation (S170F) causing Alzheimer disease with Lewy bodies in the third decade of life
BJ Snider et al.
ARCHIVES OF NEUROLOGY (2005)
α-synuclein cooperates with CSPα in preventing neurodegeneration
S Chandra et al.
CELL (2005)
Structure and dynamics of micelle-bound human α-synuclein
TS Ulmer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Release of long-range tertiary interactions potentiates aggregation of natively unstructured α-synuclein
CW Bertoncini et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Alpha-synuclein lesions in normal aging, Parkinson disease, and Alzheimer disease: Evidence from the Baltimore Longitudinal Study of Aging (BLSA)
I Mikolaenko et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2005)
Mapping long-range interactions in α-synuclein using spin-label NMR and ensemble molecular dynamics simulations
MM Dedmon et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2005)
Dementia with Lewy bodies: Reclassification of pathological subtypes and boundary with Parkinson's disease or Alzheimer's disease
E Iseki
NEUROPATHOLOGY (2004)
The new mutation, E46K, of α-synuclein causes Parkinson and Lewy body dementia
JJ Zarranz et al.
ANNALS OF NEUROLOGY (2004)
Mice lacking α-synuclein have an attenuated loss of striatal dopamine following prolonged chronic MPTP administration
RE Drolet et al.
NEUROTOXICOLOGY (2004)
Impaired degradation of mutant α-synuclein by chaperone-mediated autophagy
AM Cuervo et al.
SCIENCE (2004)
α-synuclein produces a long-lasting increase in neurotransmitter release
SM Liu et al.
EMBO JOURNAL (2004)
Double-knockout mice for α- and β-synucleins:: Effect on synaptic functions
S Chandra et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
The association of α-synuclein with membranes affects bilayer structure, stability, and fibril formation
M Zhu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Parkinson's disease-associated α-synuclein is a calmodulin substrate
J Martinez et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Initiation and synergistic fibrillization of tau and alpha-synuclein
BI Giasson et al.
SCIENCE (2003)
The N-terminal repeat domain of α-synuclein inhibits β-sheet and amyloid fibril formation
JC Kessler et al.
BIOCHEMISTRY (2003)
Neurons expressing the highest levels of gamma-synuclein are unaffected by targeted inactivation of the gene
N Ninkina et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Structural and functional implications of C-terminal regions of α-synuclein
TD Kim et al.
BIOCHEMISTRY (2002)
Structural transformation and aggregation of human α-synuclein in trifluoroethanol:: Non-amyloid component sequence is essential and β-sheet formation is prerequisite to aggregation
HT Li et al.
BIOPOLYMERS (2002)
β-Amyloid peptides enhance α-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease
E Masliah et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
A hydrophobic stretch of 12 amino acid residues in the middle of α-synuclein is essential for filament assembly
BI Giasson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
α-Synuclein-positive structures in cases with sporadic Alzheimer's disease:: morphology and its relationship to tau aggregation
Y Arai et al.
BRAIN RESEARCH (2001)
Lewy body variant of Alzheimer's disease:: α-synuclein in dystrophic neurites of Aβ plaques
O Wirths et al.
NEUROREPORT (2000)
Oxidative damage linked to neurodegeneration by selective α-synuclein nitration in synucleinopathy lesions
BI Giasson et al.
SCIENCE (2000)
Occurrence of human α-synuclein immunoreactive neurons with neurofibrillary tangle formation in the limbic areas of patients with Alzheimer's disease
W Marui et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2000)
Synucleins are developmentally expressed, and α-synuclein regulates the size of the presynaptic vesicular pool in primary hippocampal neurons
DD Murphy et al.
JOURNAL OF NEUROSCIENCE (2000)
Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system
A Abeliovich et al.
NEURON (2000)
分享论文
